Latest Aquilo Capital Management, LLC Stock Portfolio
Aquilo Capital Management, LLC Performance:
2025 Q1: -17.67%YTD: -17.67%2024: -23.24%
Performance for 2025 Q1 is -17.67%, and YTD is -17.67%, and 2024 is -23.24%.
About Aquilo Capital Management, LLC and 13F Hedge Fund Stock Holdings
Aquilo Capital Management, LLC is a hedge fund based in SAN FRANCISCO, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $442.5 Millions. In it's latest 13F Holdings report, Aquilo Capital Management, LLC reported an equity portfolio of $55.8 Millions as of 31 Mar, 2025.
The top stock holdings of Aquilo Capital Management, LLC are BPMC, ARWR, PTGX. The fund has invested 13.3% of it's portfolio in BLUEPRINT MEDICINES CORP and 12.6% of portfolio in ARROWHEAD PHARMACEUTICALS IN.
The fund managers got completely rid off SILENCE THERAPEUTICS PLC and SUTRO BIOPHARMA INC (STRO) stocks. They significantly reduced their stock positions in BLUEPRINT MEDICINES CORP (BPMC), KYMERA THERAPEUTICS INC (KYMR) and BICYCLE THERAPEUTICS PLC (BCYC). Aquilo Capital Management, LLC opened new stock positions in ZYMEWORKS INC (ZYME). The fund showed a lot of confidence in some stocks as they added substantially to PRECISION BIOSCIENCES INC (DTIL), ARVINAS INC (ARVN) and PROTAGONIST THERAPEUTICS INC (PTGX).
The top stock holdings of Aquilo Capital Management, LLC are BPMC, ARWR, PTGX. The fund has invested 13.3% of it's portfolio in BLUEPRINT MEDICINES CORP and 12.6% of portfolio in ARROWHEAD PHARMACEUTICALS IN.
The fund managers got completely rid off SILENCE THERAPEUTICS PLC and SUTRO BIOPHARMA INC (STRO) stocks. They significantly reduced their stock positions in BLUEPRINT MEDICINES CORP (BPMC), KYMERA THERAPEUTICS INC (KYMR) and BICYCLE THERAPEUTICS PLC (BCYC). Aquilo Capital Management, LLC opened new stock positions in ZYMEWORKS INC (ZYME). The fund showed a lot of confidence in some stocks as they added substantially to PRECISION BIOSCIENCES INC (DTIL), ARVINAS INC (ARVN) and PROTAGONIST THERAPEUTICS INC (PTGX).
Aquilo Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Aquilo Capital Management, LLC made a return of -17.67% in the last quarter. In trailing 12 months, it's portfolio return was -44.26%.
New Buys
| Ticker | $ Bought |
|---|---|
| zymeworks inc | 1,006,180 |
New stocks bought by Aquilo Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| precision biosciences inc | 35.38 |
| arvinas inc | 9.73 |
| protagonist therapeutics inc | 6.66 |
Additions to existing portfolio by Aquilo Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| blueprint medicines corp | -35.24 |
| kymera therapeutics inc | -24.52 |
| bicycle therapeutics plc | -22.63 |
| arrowhead pharmaceuticals in | -22.25 |
| regenxbio inc | -21.66 |
| immatics n.v | -18.45 |
| adicet bio inc | -2.96 |
Aquilo Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| silence therapeutics plc | -2,526,430 |
| sutro biopharma inc | -916 |
Aquilo Capital Management, LLC got rid off the above stocks
Sector Distribution
Aquilo Capital Management, LLC has about 93.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 93.6 |
| Others | 6.4 |
Market Cap. Distribution
Aquilo Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 59.8 |
| MICRO-CAP | 17.8 |
| SMALL-CAP | 16 |
| UNALLOCATED | 6.4 |
Stocks belong to which Index?
About 79.6% of the stocks held by Aquilo Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 79.6 |
| Others | 20.4 |
Aquilo Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aquilo Capital Management, LLC
Aquilo Capital Management, LLC has 12 stocks in it's portfolio. ARVN proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for Aquilo Capital Management, LLC last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 3.33 | 2,456,190 | 1,854,430 | reduced | -2.96 | ||
| ARVN | arvinas inc | 4.54 | 360,766 | 2,532,580 | added | 9.73 | ||
| ARWR | arrowhead pharmaceuticals in | 12.57 | 550,130 | 7,008,660 | reduced | -22.25 | ||
| BCYC | bicycle therapeutics plc | 2.61 | 171,695 | 1,457,690 | reduced | -22.63 | ||
| BPMC | blueprint medicines corp | 13.32 | 83,926 | 7,428,290 | reduced | -35.24 | ||
| DTIL | precision biosciences inc | 6.21 | 726,149 | 3,463,730 | added | 35.38 | ||
| KYMR | kymera therapeutics inc | 6.80 | 138,521 | 3,791,320 | reduced | -24.52 | ||
| PTGX | protagonist therapeutics inc | 7.08 | 81,692 | 3,950,620 | added | 6.66 | ||
| RGNX | regenxbio inc | 3.48 | 271,302 | 1,939,810 | reduced | -21.66 | ||
| RPTX | repare therapeutics inc | 2.29 | 1,293,720 | 1,275,470 | unchanged | 0.00 | ||
| STRO | sutro biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ZYME | zymeworks inc | 1.80 | 84,482 | 1,006,180 | new | |||
| immatics n.v | 2.46 | 304,902 | 1,375,110 | reduced | -18.45 | |||
| silence therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | |||